Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1089
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Nilotinib as first-line therapy for chronic myeloid leukemia

Vaid A

Year : 2011| Volume: 48| Issue : 4 | Page no: 438-445

   This article has been cited by
1 Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades
Mohd. Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H. Alkhaldi, Abeer K. Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida, Saleh I. Alaqel, Ozair Alam, Md. Afroz Bakht
Pharmaceuticals. 2021; 14(8): 710
[Pubmed]  [Google Scholar] [DOI]
2 Amyloid -induced elevation of O-GlcNAcylated c-Fos promotes neuronal cell death
Heesun Choi,Chaeyoung Kim,Hyundong Song,Moon-Yong Cha,Hyun Jin Cho,Sung Min Son,Haeng Jun Kim,Inhee Mook-Jung
Aging Cell. 2019; 18(1): e12872
[Pubmed]  [Google Scholar] [DOI]
3 Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
Mariana M. Fachi,Fernanda S. Tonin,Leticia P. Leonart,Karina S. Aguiar,Luana Lenzi,Bonald C. Figueiredo,Fernando Fernandez-Llimos,Roberto Pontarolo
European Journal of Cancer. 2018; 104: 9
[Pubmed]  [Google Scholar] [DOI]
4 Management of gastrointestinal stromal tumor: The lmatinib era and beyond
Parikh, P.M. and Gupta, S.
Indian Journal of Cancer. 2013; 50(1): 31-40
[Pubmed]  [Google Scholar]
5 Optimizing second-line therapy for chronic myeloid leukemia
Raja, T.
Indian Journal of Cancer. 2012; 49(1): 46-56
[Pubmed]  [Google Scholar]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow